BRAF and thyroid cancer: Using thyroid cancer cell line expressing either wild-type BRAF or V600E-mutant BRAF, Choi et al. [47] observed that AICAR treatment induced a decrease in the cell proliferation rate associated with increased S-phase cell-cycle arrest and apoptosis.